{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:28:46Z","timestamp":1793824126488,"version":"4.6.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Innovation Project for Postgraduate Students of Hunan University of Chinese Medicine","award":["2025CX023"],"award-info":[{"award-number":["2025CX023"]}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["025JJ70415"],"award-info":[{"award-number":["025JJ70415"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Project of the Hunan Provincial Department of Education","award":["24A0765"],"award-info":[{"award-number":["24A0765"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Proced Online"],"DOI":"10.1186\/s12575-025-00321-1","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:45:30Z","timestamp":1767854730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated Bioinformatics and Experimental Validation Reveal Fuzheng Yi\u2019ai Formula Induces Immunogenic Cell Death Via the PERK-eIF2\u03b1-ATF4 Pathway for Prostate Cancer Treatment"],"prefix":"10.1186","volume":"28","author":[{"given":"Xiaopeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"3","key":"321_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"321_CR2","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/ijms19030904","volume":"19","author":"CA Wade","year":"2018","unstructured":"Wade CA, Kyprianou N. Profiling prostate cancer therapeutic resistance. Int J Mol Sci. 2018;19(3):904.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"321_CR3","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s12094-022-02857-0","volume":"24","author":"J Liao","year":"2022","unstructured":"Liao J, Ye Y, Xu X. Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer. Clin Transl Oncol. 2022;24(10):1986\u201397.","journal-title":"Clin Transl Oncol"},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"1001297","DOI":"10.3389\/fimmu.2022.1001297","volume":"13","author":"W Wu","year":"2022","unstructured":"Wu W, Wang X, Le W, et al. Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer. Front Immunol. 2022;13:1001297.","journal-title":"Front Immunol"},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"0039","DOI":"10.34133\/bmr.0039","volume":"28","author":"Y Luo","year":"2024","unstructured":"Luo Y, Luo X, Ru Y, et al. Copper(II)-Based Nano-Regulator correlates Cuproptosis burst and sequential Immunogenic cell death for synergistic cancer immunotherapy. Biomater Res. 2024;28:0039.","journal-title":"Biomater Res"},{"issue":"1","key":"321_CR6","doi-asserted-by":"publisher","first-page":"23231","DOI":"10.1038\/s41598-024-72697-1","volume":"14","author":"S Jafari","year":"2024","unstructured":"Jafari S, Ardakan AK, Aghdam EM, Mesbahi A, Montazersaheb S, Molavi O. Induction of Immunogenic cell death and enhancement of the radiation-induced Immunogenicity by Chrysin in melanoma cancer cells. Sci Rep. 2024;14(1):23231.","journal-title":"Sci Rep"},{"issue":"5","key":"321_CR7","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1038\/cddis.2013.156","volume":"4","author":"O Krysko","year":"2013","unstructured":"Krysko O, L\u00f8ve Aaes T, Bachert C, Vandenabeele P, Krysko DV. Many faces of damps in cancer therapy. Cell Death Dis. 2013;4(5):e631.","journal-title":"Cell Death Dis"},{"issue":"12","key":"321_CR8","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Tait S. Targeting Immunogenic cell death in cancer. Mol Oncol. 2020;14(12):2994\u20133006.","journal-title":"Mol Oncol"},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.imlet.2017.11.006","volume":"193","author":"J Fucikova","year":"2018","unstructured":"Fucikova J, Kasikova L, Truxova I, et al. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer. Immunol Lett. 2018;193:25\u201334.","journal-title":"Immunol Lett"},{"issue":"22","key":"321_CR10","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.3390\/cells11223672","volume":"11","author":"N Roussot","year":"2022","unstructured":"Roussot N, Ghiringhelli F, R\u00e9b\u00e9 C. Tumor Immunogenic cell death as a mediator of intratumor CD8 T-Cell recruitment. Cells. 2022;11(22):3672.","journal-title":"Cells"},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"216435","DOI":"10.1016\/j.canlet.2023.216435","volume":"577","author":"MY Zhu","year":"2023","unstructured":"Zhu MY, Wang T, Wang HD, et al. LW-213 induces Immunogenic tumor cell death via ER stress mediated by lysosomal TRPML1. Cancer Lett. 2023;577:216435.","journal-title":"Cancer Lett"},{"issue":"14","key":"321_CR12","doi-asserted-by":"publisher","first-page":"20833","DOI":"10.1021\/acsami.5c00184","volume":"17","author":"S Jin","year":"2025","unstructured":"Jin S, Chen Y, Li F, et al. Photodynamic and photothermal Co-Induced efficient Anti-Tumor immunotherapy. ACS Appl Mater Interfaces. 2025;17(14):20833\u201348.","journal-title":"ACS Appl Mater Interfaces"},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"118569","DOI":"10.1016\/j.jep.2024.118569","volume":"334","author":"H Cai","year":"2024","unstructured":"Cai H, Zhang Y, Wang J, et al. D-glucaro-1,4-lactone improves diethylnitrosamine induced hepatocellular carcinoma in rats via the uric acid-ROS pathway. J Ethnopharmacol. 2024;334:118569.","journal-title":"J Ethnopharmacol"},{"issue":"9","key":"321_CR14","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.3390\/molecules15096217","volume":"15","author":"W Zhou","year":"2010","unstructured":"Zhou W, Su SL, Duan JA, et al. Characterization of the active constituents in Shixiao San using bioactivity evaluation followed by UPLC-QTOF and Markerlynx analysis. Molecules. 2010;15(9):6217\u201330.","journal-title":"Molecules"},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"115746","DOI":"10.1016\/j.jep.2022.115746","volume":"301","author":"X Wei","year":"2023","unstructured":"Wei X, Gao M, Sheng N, et al. Mechanism investigation of Shi-Xiao-San in treating blood stasis syndrome based on network pharmacology, molecular Docking and in vitro\/vivo Pharmacological validation. J Ethnopharmacol. 2023;301:115746.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"321_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13223-023-00792-5","volume":"19","author":"JJ Tsai","year":"2023","unstructured":"Tsai JJ, Yen CY, Hsu CH, Yu SJ, Chen CH, Liao EC. Immunomodulatory effects of modified Liu-Wei-Di-Huang-Wan traditional Chinese medicine on allergic asthmatic mice. Allergy Asthma Clin Immunol. 2023;19(1):35.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"2","key":"321_CR17","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1142\/S0192415X03000886","volume":"31","author":"JJ Shen","year":"2003","unstructured":"Shen JJ, Lin CJ, Huang JL, Hsieh KH, Kuo ML. The effect of liu-wei-di-huang Wan on cytokine gene expression from human peripheral blood lymphocytes. Am J Chin Med. 2003;31(2):247\u201357.","journal-title":"Am J Chin Med"},{"key":"321_CR18","doi-asserted-by":"publisher","first-page":"102332","DOI":"10.1016\/j.ctim.2020.102332","volume":"49","author":"HL Lu","year":"2020","unstructured":"Lu HL, Su YC, Lin MC, Sun MF, Huang ST. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study. Complement Ther Med. 2020;49:102332.","journal-title":"Complement Ther Med"},{"issue":"9","key":"321_CR19","first-page":"3491","volume":"27","author":"RJ Lim","year":"2019","unstructured":"Lim RJ, Nik Nabil WN, Chan SY, et al. Effects of herbal medicine for Xerostomia in head and neck cancer patients: an observational study in a tertiary cancer hospital. Support Care Cancer. 2019;27(9):3491\u20138.","journal-title":"Support Care Cancer"},{"key":"321_CR20","doi-asserted-by":"publisher","first-page":"116565","DOI":"10.1016\/j.jep.2023.116565","volume":"314","author":"S Wu","year":"2023","unstructured":"Wu S, Sun Z, Guo Z, et al. The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review. J Ethnopharmacol. 2023;314:116565.","journal-title":"J Ethnopharmacol"},{"key":"321_CR21","doi-asserted-by":"publisher","first-page":"115121","DOI":"10.1016\/j.jep.2022.115121","volume":"290","author":"D Yue","year":"2022","unstructured":"Yue D, Zheng Z, Fan W, et al. Effect of Shixiao San on inflammatory factors and pain in rats with endometriosis. J Ethnopharmacol. 2022;290:115121.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"321_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s12013-015-0532-9","volume":"72","author":"P Zhang","year":"2015","unstructured":"Zhang P, Zhang B, Gu J, Hao L, Hu F, Han C. The study of the effect of Hedyotis diffusa on the proliferation and the apoptosis of the cervical tumor in nude mouse model. Cell Biochem Biophys. 2015;72(3):783\u20139.","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"321_CR23","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3892\/etm.2012.599","volume":"4","author":"M Lin","year":"2012","unstructured":"Lin M, Lin J, Wei L, et al. Hedyotis diffusa willd extract inhibits HT-29 cell proliferation via cell cycle arrest. Exp Ther Med. 2012;4(2):307\u201310.","journal-title":"Exp Ther Med"},{"issue":"1","key":"321_CR24","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3892\/mmr.2015.3473","volume":"12","author":"Y Zhou","year":"2015","unstructured":"Zhou Y, Shen J, Xia L, Wang Y. Curcuma Zedoaria (Berg.) Rosc. Essential oil and Paclitaxel synergistically enhance the apoptosis of SKOV3 cells. Mol Med Rep. 2015;12(1):1253\u20137.","journal-title":"Mol Med Rep"},{"issue":"Pt 4","key":"321_CR25","doi-asserted-by":"publisher","first-page":"141013","DOI":"10.1016\/j.ijbiomac.2025.141013","volume":"306","author":"L Bai","year":"2025","unstructured":"Bai L, Liu X, Yuan Z, et al. Activation of IL-2\/IL-2R pathway by Hedyotis diffusa polysaccharide improves immunotherapy in colorectal cancer. Int J Biol Macromol. 2025;306(Pt 4):141013.","journal-title":"Int J Biol Macromol"},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"156137","DOI":"10.1016\/j.phymed.2024.156137","volume":"135","author":"J Yi","year":"2024","unstructured":"Yi J, Ye Z, Xu H, et al. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived Exosomal miR-92b-5p. Phytomedicine. 2024;135:156137.","journal-title":"Phytomedicine"},{"issue":"5","key":"321_CR27","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1007\/s10787-025-01739-5","volume":"33","author":"P Goleij","year":"2025","unstructured":"Goleij P, Rezaee A, Lam HY, et al. From bench to bedside: exploring curcumin-driven signaling pathways in immune cells for cancer management. Inflammopharmacology. 2025;33(5):2293\u2013306.","journal-title":"Inflammopharmacology"},{"issue":"3","key":"321_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jgr.2019.01.008","volume":"44","author":"JH Shang","year":"2020","unstructured":"Shang JH, Sun WJ, Zhu HT, Wang D, Yang CR, Zhang YJ. New hydroperoxylated and 20,24-epoxylated Dammarane triterpenes from the rot roots of Panax Notoginseng. J Ginseng Res. 2020;44(3):405\u201312.","journal-title":"J Ginseng Res"},{"issue":"29\u201330","key":"321_CR29","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1016\/j.vaccine.2004.04.012","volume":"22","author":"HX Sun","year":"2004","unstructured":"Sun HX, Ye YP, Pan HJ, Pan YJ. Adjuvant effect of Panax Notoginseng saponins on the immune responses to ovalbumin in mice. Vaccine. 2004;22(29\u201330):3882\u20139.","journal-title":"Vaccine"},{"issue":"3","key":"321_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jep.2014.04.037","volume":"154","author":"P Wang","year":"2014","unstructured":"Wang P, Cui J, Du X, et al. Panax Notoginseng saponins (PNS) inhibits breast cancer metastasis. J Ethnopharmacol. 2014;154(3):663\u201371.","journal-title":"J Ethnopharmacol"},{"issue":"10","key":"321_CR31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/01635581.2024.2383336","volume":"76","author":"J Ding","year":"2024","unstructured":"Ding J, Li C, Wang G, Yang Y, Li J. Cancer-Related therapeutic potential of epimedium and its extracts. Nutr Cancer. 2024;76(10):885\u2013901.","journal-title":"Nutr Cancer"},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jep.2017.06.014","volume":"207","author":"C Wang","year":"2017","unstructured":"Wang C, Feng L, Su J, et al. Polysaccharides from epimedium Koreanum Nakai with Immunomodulatory activity and inhibitory effect on tumor growth in LLC-bearing mice. J Ethnopharmacol. 2017;207:8\u201318.","journal-title":"J Ethnopharmacol"},{"issue":"11","key":"321_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.14715\/cmb\/2017.63.11.22","volume":"63","author":"Y Liu","year":"2017","unstructured":"Liu Y, Zuo H, Liu X, Xiong J, Pei X. The antiosteoporosis effect of Icariin in ovariectomized rats: a systematic review and meta-analysis. Cell Mol Biol (Noisy-le-grand). 2017;63(11):124\u201331.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"321_CR34","doi-asserted-by":"publisher","first-page":"118024","DOI":"10.1016\/j.jep.2024.118024","volume":"328","author":"R Liu","year":"2024","unstructured":"Liu R, Zhang X, Cai Y, et al. Research progress on medicinal components and Pharmacological activities of polygonatum sibiricum. J Ethnopharmacol. 2024;328:118024.","journal-title":"J Ethnopharmacol"},{"key":"321_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jep.2017.12.006","volume":"214","author":"P Zhao","year":"2018","unstructured":"Zhao P, Zhao C, Li X, et al. The genus polygonatum: A review of ethnopharmacology, phytochemistry and Pharmacology. J Ethnopharmacol. 2018;214:274\u201391.","journal-title":"J Ethnopharmacol"},{"key":"321_CR36","doi-asserted-by":"crossref","unstructured":"Yu X, Tang Y, Niu J, Hu J. Integrated multidimensional bioinformatics analysis of the molecular mechanisms of ulcerative colitis-associated colorectal cancer and MMP1 as a potential therapeutic target. Cancer Gene Ther. 2025;32(9):973\u201384.","DOI":"10.1038\/s41417-025-00917-5"},{"key":"321_CR37","doi-asserted-by":"publisher","first-page":"118281","DOI":"10.1016\/j.ecoenv.2025.118281","volume":"298","author":"X Yu","year":"2025","unstructured":"Yu X, Niu J, Hu J. Multidimensional bioinformatics analysis reveals the potential carcinogenic role of acrylamide in colorectal cancer. Ecotoxicol Environ Saf. 2025;298:118281.","journal-title":"Ecotoxicol Environ Saf"},{"key":"321_CR38","doi-asserted-by":"crossref","unstructured":"Yu X, Lei J, Du X, et al. A multi-dimensional bioinformatic dissection of the molecular mechanisms in high BMI-associated colorectal cancer: identification and validation of EGLN1 as a key target. Int J Surg. Online ahead of print 2025; PMID: 41191606.","DOI":"10.1097\/JS9.0000000000003801"},{"issue":"169","key":"321_CR39","doi-asserted-by":"publisher","first-page":"169ra10","DOI":"10.1126\/scitranslmed.3005211","volume":"5","author":"MJ Aryee","year":"2013","unstructured":"Aryee MJ, Liu W, Engelmann JC, et al. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. Sci Transl Med. 2013;5(169):169ra10.","journal-title":"Sci Transl Med"},{"issue":"1","key":"321_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/gepi.22506","volume":"47","author":"A Gkatzionis","year":"2023","unstructured":"Gkatzionis A, Burgess S, Newcombe PJ. Statistical methods for cis-Mendelian randomization with two-sample summary-level data. Genet Epidemiol. 2023;47(1):3\u201325.","journal-title":"Genet Epidemiol"},{"issue":"3","key":"321_CR41","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011;40(3):740\u201352.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"321_CR42","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5808\/GI.2016.14.4.173","volume":"14","author":"CH Lee","year":"2016","unstructured":"Lee CH, Cook S, Lee JS, Han B. Comparison of two Meta-Analysis methods: Inverse-Variance-Weighted average and weighted sum of Z-Scores. Genomics Inf. 2016;14(4):173\u201380.","journal-title":"Genomics Inf"},{"key":"321_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"321_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"1","key":"321_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jep.2012.09.055","volume":"145","author":"Y Cheng","year":"2013","unstructured":"Cheng Y, Liu Y, Wang H, et al. A 26-week repeated dose toxicity study of Xian-ling-gu-bao in Sprague-Dawley rats. J Ethnopharmacol. 2013;145(1):85\u201393.","journal-title":"J Ethnopharmacol"},{"key":"321_CR46","doi-asserted-by":"publisher","first-page":"830972","DOI":"10.3389\/fphar.2022.830972","volume":"13","author":"RJ Griffin","year":"2022","unstructured":"Griffin RJ, Avery E, Xia CQ. Predicting approximate clinically effective doses in oncology using preclinical efficacy and body surface area conversion: A retrospective analysis. Front Pharmacol. 2022;13:830972.","journal-title":"Front Pharmacol"},{"key":"321_CR47","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"4","key":"321_CR48","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"issue":"2","key":"321_CR49","doi-asserted-by":"publisher","first-page":"e20210564","DOI":"10.1084\/jem.20210564","volume":"219","author":"M Masetti","year":"2022","unstructured":"Masetti M, Carriero R, Portale F, et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med. 2022;219(2):e20210564.","journal-title":"J Exp Med"},{"issue":"4","key":"321_CR50","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41419-021-03605-y","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Zheng J, Chen S, Meng FD, Ning J, Sun SL. Oleandrin, a cardiac glycoside, induces Immunogenic cell death via the PERK\/elF2\u03b1\/ATF4\/CHOP pathway in breast cancer. Cell Death Dis. 2021;12(4):314.","journal-title":"Cell Death Dis"},{"issue":"1","key":"321_CR51","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12964-023-01190-5","volume":"21","author":"TH Tran","year":"2023","unstructured":"Tran TH, Kao M, Liu HS, Hong YR, Su Y, Huang CF. Repurposing thioridazine for inducing Immunogenic cell death in colorectal cancer via eIF2\u03b1\/ATF4\/CHOP and secretory autophagy pathways. Cell Commun Signal. 2023;21(1):184.","journal-title":"Cell Commun Signal"},{"issue":"12","key":"321_CR52","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/md21120600","volume":"21","author":"Y Huang","year":"2023","unstructured":"Huang Y, Yan H, Zhang B, et al. Ascomylactam C induces an Immunogenic cell death signature via Mitochondria-Associated ER stress in lung cancer and melanoma. Mar Drugs. 2023;21(12):600.","journal-title":"Mar Drugs"},{"key":"321_CR53","doi-asserted-by":"publisher","first-page":"100087","DOI":"10.1016\/j.crphar.2022.100087","volume":"3","author":"C Gundu","year":"2022","unstructured":"Gundu C, Arruri VK, Sherkhane B, Khatri DK, Singh SB. GSK2606414 attenuates PERK\/p-eIF2\u03b1\/ATF4\/CHOP axis and augments mitochondrial function to mitigate high glucose induced neurotoxicity in N2A cells. Curr Res Pharmacol Drug Discov. 2022;3:100087.","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"321_CR54","doi-asserted-by":"publisher","first-page":"214339","DOI":"10.1016\/j.bioadv.2025.214339","volume":"176","author":"X Yan","year":"2025","unstructured":"Yan X, Dong H, Gao L, Liu M, Wang C. Mechanism of selenium-doped black phosphorus nanosheets wrapped with biomimetic tumor cell membrane for prostate cancer immunotherapy. Biomater Adv. 2025;176:214339.","journal-title":"Biomater Adv"},{"issue":"1","key":"321_CR55","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00345-025-05760-9","volume":"43","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Maggs L, Zhou K, et al. Piperlongumine enhances the antitumor efficacy of PD-1 inhibitors by inducing Immunogenic cell death in prostate cancer cells. World J Urol. 2025;43(1):406.","journal-title":"World J Urol"},{"key":"321_CR56","doi-asserted-by":"publisher","first-page":"21146","DOI":"10.1038\/srep21146","volume":"6","author":"Z Liu","year":"2016","unstructured":"Liu Z, Guo F, Wang Y, et al. BATMAN-TCM: a bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine. Sci Rep. 2016;6:21146.","journal-title":"Sci Rep"},{"key":"321_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2015.03.010","volume":"48","author":"MG Frank","year":"2015","unstructured":"Frank MG, Weber MD, Watkins LR, Maier SF. Stress sounds the alarmin: the role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming. Brain Behav Immun. 2015;48:1\u20137.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"321_CR58","doi-asserted-by":"publisher","first-page":"e004151","DOI":"10.1136\/jitc-2021-004151","volume":"10","author":"L Bezu","year":"2022","unstructured":"Bezu L, Wu Chuang A, Sauvat A, et al. Local anesthetics elicit immune-dependent anticancer effects. J Immunother Cancer. 2022;10(4):e004151.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"321_CR59","doi-asserted-by":"publisher","first-page":"14915","DOI":"10.1038\/s41598-017-14848-1","volume":"7","author":"P Liu","year":"2017","unstructured":"Liu P, Zhao L, Loos F, et al. Identification of Pharmacological agents that induce HMGB1 release. Sci Rep. 2017;7(1):14915.","journal-title":"Sci Rep"},{"issue":"6","key":"321_CR60","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1039\/D5MD00039D","volume":"16","author":"C Donati","year":"2025","unstructured":"Donati C, Hashim II, Pozsoni NB, et al. Investigation of the in vitro anticancer potential of bis(imino)acenaphthene-N-heterocyclic carbene transition metal complexes revealed TrxR Inhibition and triggering of Immunogenic cell death (ICD) for allyl palladates. RSC Med Chem. 2025;16(6):2592\u2013602.","journal-title":"RSC Med Chem"},{"key":"321_CR61","doi-asserted-by":"publisher","first-page":"747837","DOI":"10.3389\/fphar.2021.747837","volume":"12","author":"X Tian","year":"2021","unstructured":"Tian X, Zhang S, Zhou L, et al. Targeting the integrated stress response in cancer therapy. Front Pharmacol. 2021;12:747837.","journal-title":"Front Pharmacol"},{"issue":"1","key":"321_CR62","doi-asserted-by":"publisher","first-page":"22938","DOI":"10.1038\/s41598-024-74391-8","volume":"14","author":"E van Zyl","year":"2024","unstructured":"van Zyl E, Stead J, Peneycad C, Yauk CL, McKay BC. Activating transcription factor 4 plays a major role in shaping the transcriptional response to Isoginkgetin in HCT116 cells. Sci Rep. 2024;14(1):22938.","journal-title":"Sci Rep"},{"issue":"1","key":"321_CR63","doi-asserted-by":"publisher","first-page":"14161","DOI":"10.1038\/s41598-021-93663-1","volume":"11","author":"NI Lorenz","year":"2021","unstructured":"Lorenz NI, Sittig A, Urban H, et al. Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and Temozolomide. Sci Rep. 2021;11(1):14161.","journal-title":"Sci Rep"},{"key":"321_CR64","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.imlet.2020.09.006","volume":"228","author":"D Mukherjee","year":"2020","unstructured":"Mukherjee D, Bercz LS, Torok MA, Mace TA. Regulation of cellular immunity by activating transcription factor 4. Immunol Lett. 2020;228:24\u201334.","journal-title":"Immunol Lett"},{"issue":"5","key":"321_CR65","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00262-020-02740-3","volume":"70","author":"AM Andrews","year":"2021","unstructured":"Andrews AM, Tennant MD, Thaxton JE. Stress relief for cancer immunotherapy: implications for the ER stress response in tumor immunity. Cancer Immunol Immunother. 2021;70(5):1165\u201375.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"321_CR66","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s12672-024-01485-0","volume":"15","author":"Y Lu","year":"2024","unstructured":"Lu Y, Chen W, Xuan Y, et al. ATF4\/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma. Discov Oncol. 2024;15(1):607.","journal-title":"Discov Oncol"},{"key":"321_CR67","doi-asserted-by":"publisher","first-page":"1541509","DOI":"10.3389\/fphar.2025.1541509","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Liu X, Zhou J, Li F, Wang Y, Liu Q. Artificial intelligence in traditional Chinese medicine: advances in multi-metabolite multi-target interaction modeling. Front Pharmacol. 2025;16:1541509.","journal-title":"Front Pharmacol"},{"issue":"4","key":"321_CR68","doi-asserted-by":"publisher","first-page":"101199","DOI":"10.1016\/j.jpha.2025.101199","volume":"15","author":"Z Yu","year":"2025","unstructured":"Yu Z, Li T, Zheng Z, et al. Tailoring a traditional Chinese medicine prescription for complex diseases: A novel multi-targets-directed gradient weighting strategy. J Pharm Anal. 2025;15(4):101199.","journal-title":"J Pharm Anal"},{"issue":"25","key":"321_CR69","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1182\/blood.2023022777","volume":"143","author":"A Gulla","year":"2024","unstructured":"Gulla A, Morelli E, Johnstone M, et al. Loss of GABARAP mediates resistance to Immunogenic chemotherapy in multiple myeloma. Blood. 2024;143(25):2612\u201326.","journal-title":"Blood"},{"key":"321_CR70","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.3389\/fimmu.2019.02524","volume":"10","author":"R Zhao","year":"2019","unstructured":"Zhao R, Qiao J, Zhang X, et al. Toll-Like Receptor-Mediated Activation of CD39 Internalization in BMDCs Leads to Extracellular ATP Accumulation and Facilitates P2X7 Receptor Activation. Front Immunol. 2019;10:2524.","journal-title":"Front Immunol"},{"issue":"3","key":"321_CR71","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1158\/0008-5472.CAN-09-3566","volume":"70","author":"L Aymeric","year":"2010","unstructured":"Aymeric L, Apetoh L, Ghiringhelli F, et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res. 2010;70(3):855\u20138.","journal-title":"Cancer Res"},{"issue":"2","key":"321_CR72","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/cmi.2013.59","volume":"11","author":"H Fang","year":"2014","unstructured":"Fang H, Ang B, Xu X, et al. TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by damps released from chemically stressed cancer cells. Cell Mol Immunol. 2014;11(2):150\u20139.","journal-title":"Cell Mol Immunol"},{"key":"321_CR73","doi-asserted-by":"publisher","first-page":"155219","DOI":"10.1016\/j.phymed.2023.155219","volume":"123","author":"Q Hu","year":"2024","unstructured":"Hu Q, Wang S, Cheng R, et al. Tannins in phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting Endoplasmic reticulum stress to trigger Immunogenic cell death. Phytomedicine. 2024;123:155219.","journal-title":"Phytomedicine"},{"issue":"6","key":"321_CR74","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s13402-020-00544-2","volume":"43","author":"C Li","year":"2020","unstructured":"Li C, Sun H, Wei W, et al. Mitoxantrone triggers Immunogenic prostate cancer cell death via p53-dependent PERK expression. Cell Oncol (Dordr). 2020;43(6):1099\u2013116.","journal-title":"Cell Oncol (Dordr)"},{"key":"321_CR75","doi-asserted-by":"publisher","first-page":"115057","DOI":"10.1016\/j.intimp.2025.115057","volume":"162","author":"W Xiong","year":"2025","unstructured":"Xiong W, Liu Y, Yang H, et al. Short-term high-dose gemcitabine induces PERK-mediated Immunogenic cell death and potentiates antitumor immunity in bladder cancer. Int Immunopharmacol. 2025;162:115057.","journal-title":"Int Immunopharmacol"},{"key":"321_CR76","doi-asserted-by":"publisher","first-page":"781466","DOI":"10.3389\/fimmu.2021.781466","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Wu S, Liu F, et al. An Immunogenic cell Death-Related classification predicts prognosis and response to immunotherapy in head and neck squamous cell carcinoma. Front Immunol. 2021;12:781466.","journal-title":"Front Immunol"},{"key":"321_CR77","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2021.07.038","volume":"337","author":"A Banstola","year":"2021","unstructured":"Banstola A, Poudel K, Kim JO, Jeong JH, Yook S. Recent progress in stimuli-responsive nanosystems for inducing Immunogenic cell death. J Control Release. 2021;337:505\u201320.","journal-title":"J Control Release"},{"key":"321_CR78","doi-asserted-by":"publisher","first-page":"105295","DOI":"10.1016\/j.bioorg.2021.105295","volume":"116","author":"P Chen","year":"2021","unstructured":"Chen P, Wang S, Cao C, et al. \u03b1-naphthoflavone-derived cytochrome P450 (CYP)1B1 degraders specific for sensitizing CYP1B1-mediated drug resistance to prostate cancer DU145: structure activity relationship. Bioorg Chem. 2021;116:105295.","journal-title":"Bioorg Chem"},{"issue":"7","key":"321_CR79","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s13346-023-01505-6","volume":"14","author":"Y Xu","year":"2024","unstructured":"Xu Y, Qiu Z, Chen J, Huang L, Zhang J, Lin J. LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p\/DLL1 axis and activating Notch pathway in vitro and in vivo. Drug Deliv Transl Res. 2024;14(7):2003\u201318.","journal-title":"Drug Deliv Transl Res"},{"key":"321_CR80","doi-asserted-by":"publisher","first-page":"44218","DOI":"10.1038\/srep44218","volume":"7","author":"Y Pu","year":"2017","unstructured":"Pu Y, Zhao F, Wang H, Cai S. MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene. Sci Rep. 2017;7:44218.","journal-title":"Sci Rep"}],"container-title":["Biological Procedures Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12575-025-00321-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-025-00321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12575-025-00321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:03:51Z","timestamp":1770210231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12575-025-00321-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1186\/s12575-025-00321-1","relation":{},"ISSN":["1480-9222"],"issn-type":[{"value":"1480-9222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiment was approved by the Ethics Committee of Hunan University of Chinese Medicine (Ethics Approval Number: 202506028).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9"}}